Trial Information

Summary: A clinical study to evaluate the effect of a new treatment in patients with Prostate or Breast Cancer with Metastatic Bone Disease

To participate in the study you should fulfill the following criteria:

  • Confirmed breast cancer (female only) or prostate cancer subjects age 18 years or older
  • At least one radiographically confirmed metastatic bone lesion
  • No change of cancer therapy for at least 8 weeks

You are not able to participate if you:

  • Have any prior exposure to bisphosphonate therapy
  • Have had hip fractures or bilateral hip prothesis fracture of any kind or surgery to bone within past 12 months

Contact:

John Araujo, MD
Research Center
MD Anderson Cancer Center
155 Herman Pressler, Unit 1374
Houston, TX 77030
Telephone: 713-563-7231

This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.

Trial listings updated: February 25, 2008 at 3:18:23 PM


Back to Centerwatch Trial Listing by Location


Additional resources
in this illness area

Copyright © 1995 - 2008, CenterWatch
All Rights Reserved

This site was developed in association with Illumina Interactive, Boston, MA